Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 March 2007, Vol. 109, No. 6, pp. 2269-2270.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reisfeld, R. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Reisfeld, R. A.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Next Article next article arrow

InsideBlood

IMMUNOBIOLOGY

Comment on Mostböck et al, page 2488

Memory T cells: death by acquisition

Ralph A. Reisfeld

1 THE SCRIPPS RESEARCH INSTITUTE

In this issue of Blood, Mostböck and colleagues report that effector and rested memory T cells can acquire major histocompatibility complex (MHC)/CD80 costimulatory cell complexes (antigen presentasomes [APSs]) from antigen-presenting cells (APCs). This, in turn, provides an important checkpoint of memory T-cell homeostasis through apoptosis of the majority of effector T cells by clonal deletion, possibly allowing the surviving cells to become long-term memory T cells by default.

It is well established that the pool of peripheral lymphocytes is closely regulated and remains relatively constant in the absence of disease. However, during an immune response, the expansion of the T-cell pool is followed by a deletion of most of the newly generated effector cells, thereby restoring the total number of T cells to normal levels.1 The mechanisms involved in the elimination of effector cells that might play a role in the immunoregulation of T-cell responses have been investigated by Sabzevari and colleagues and described in a series of reports (Sabzevari et al,2 Tatari-Calderone et al,3 and Zhou et al4). Initially, these investigators demonstrated for the first time that (1) naive T cells, following acquisition of CD80 from antigen-presenting cells (APCs), were themselves capable of acting as APCs; and (2) memory T cells that acquired CD80 in this same fashion did undergo apoptosis in the presence of increased signal 1 mediated via a peptide-MHC on the APCs. These data demonstrated both immunostimulatory and immunoregulatory functions as a result of CD80 acquisition by different T-cell populations.2

In a follow-up study,3 these investigators were first to demonstrate that human CD4+ T cells can acquire CD80 upon activation with autologous or allogeneic APCs. This acquisition was mediated through CD28 receptors and played a key role, both in the activation of cells that acquired these molecules and in adjacent T cells. These findings suggested that acquisition of CD80 by T cells could play a role in regulating immune responses to pathogens or diseases of the immune system. The functional relevance of acquired CD80 by T cells was addressed by a study defining the role of this phenomenon in T-cell clonal expansion.4 A series of elegant experiments indicated that upon encountering professional APCs, naive T cells can remove an MHC/CD80 complex and that this "antigen presentasome" (APS) can sustain activation even after T cells have lost contact with APCs. This is a unique concept, since by such a mechanism naive T cells can sustain their activation via continued proliferation and interaction with neighboring naive T cells even in the absence of APCs. In fact, this mechanism allows for a maximum activation of T cells despite the limited duration of their contact with APCs and permits optimal and faster clonal expansion in vivo.

The current paper by Mostböck and colleagues in this issue of Blood indicates that effector and rested memory T cells can acquire the antigen presentasome consisting of MHC/CD80 molecules upon activation in vitro and after vaccination in vivo. This acquisition correlated with increased levels of cell death in vivo and up-regulation of caspase-3, bcl-x, bak, and bax in vitro. In addition, once memory T cells acquired the APS, they became cytotoxic T lymphocytes (CTLs) and killed other cells through perforin-mediated lysis while retaining the production of interferon {gamma} and Th2 type cytokines. In fact, the acquisition of APS by memory T cells might be an important checkpoint leading to the clonal deletion of the majority of effector T cells, while allowing the surviving cells to become long-term memory cells by default (see figure).


Figure 1
View larger version (88K):
[in this window]
[in a new window]

 
Acquisition of antigen presentasome (APS) by T cells: immunological consequences.

 
In this regard, Sprent and Tough1 hypothesized that long-term memory cells are generated by a default pathway and represent a few memory T-cell escapees that evaded cell death via multiple mechanisms. In view of this hypothesis, Mostböck and colleagues now suggest that acquisition of the APS by T cells at an early phase of activation leads to the activation and proliferation of such cells. However, once T cells enter the memory phase and acquire more APS, they may well start to interact with one another. In turn, this interaction among memory CD4/CD80acq T cells could lead to the eradication of the majority of such cells through replicative cessation or even CTL mechanisms. The few activated T cells that did not come in contact with the memory CD4/CD80acq T cells can be regarded as the few escapees that will turn into long-term memory T cells. Therefore, the acquisition of the antigen presentasome can act as a unique checkpoint for memory CD4 T-cell homeostasis, which ultimately decides the outcome of CD4 T-cell activation.

Footnotes

The author declares no conflicting financial interests. {blacksquare}

REFERENCES

  1. Sprent J and Tough DF. T cell death and memory. Science 2001; 293:245–248.[Abstract/Free Full Text]

  2. Sabzevari H, Kantor J, Jaigirdar A, et al. Acquisition of CD80 (B7-1) by T cells. J Immunol 2001; 166:2505–2513.[Abstract/Free Full Text]

  3. Tatari-Calderone Z, Semnani RT, Nutman TB, Schlom J, Sabzevari H. Acquisition of CD80 by human T cells at early stages of activation: functional involvement of CD80 acquisition in T cell to T cell interaction. J Immunol 2002; 169:6162–6169.[Abstract/Free Full Text]

  4. Zhou J, Tagaya Y, Tolouei-Semnani R, Schlom J, Sabzevari H. Physiological relevance of antigen presentasome (APS), an acquired MHC/costimulatory complex, in the sustained activation of CD4+ T cells in the absence of APCs. Blood 2005; 105:3238–3246.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Acquisition of antigen presentasome (APS), an MHC/costimulatory complex, is a checkpoint of memory T-cell homeostasis
Sven Mostböck, Marta Catalfamo, Yutaka Tagaya, Jeffrey Schlom, and Helen Sabzevari
Blood 2007 109: 2488-2495. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reisfeld, R. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Reisfeld, R. A.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020